COVID-19 Therapy and Vaccine Drug Pipeline Market Report- September 2020 Update

September 2020 | 512 pages | ID: C8518F2DBFC5EN
VPAResearch

Abstracts

The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phase 3 and around 15 companies are in Phase 2/3. Pipeline candidates of 114 companies are in phase 1 or phase 2. 23 companies are in IND/CTA filed phase.

The early development COVID-19 product pipeline is much stronger with 135 companies investing their R&D resources in preclinical COVID, 127 companies developing Research phase products.

The research report is a comprehensive market research on COVID-19 pipeline products detailing the companies, drug and vaccine candidates, their current status, historical developments and other progress.

The COVID pandemic is resulting in significant health and economic impact on individuals and businesses across the world. Accordingly, companies like Inovio, Pfizer, Johnson and Johnson, Novavax are forming joint ventures, GlaxoSmithKline is extending access to vaccine adjuvant platform, and Sanofi is sharing its expertise with BARDA among others.

Following the release of SARS-CoV-2 genome sequence, majority of companies ranging from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are focusing on vaccine candidates for COVID-19.

Report Highlights

• The current COVID-19 pipeline is characterized by active operations of 24 companies including large players - AbCellera Biologics, Ansun Biopharma, AryoGen, AstraZeneca, Bellerophon Therapeutics, Biocad, CytoDyn, Eli Lilly and Company, FUJIFILM Toyama Chemical, Fulcrum Therapeutics, Gilead Sciences, Insmed Inc, International Biotech Center, Kowsar Biotechnology, Moderna Therapeutics, Octapharma, OncoImmune, Regeneron Pharmaceuticals, Romark Laboratories, Serum Institute of India, Sinovac Biotech, Swedish Orphan Biovitrum AB, Vanda Pharmaceuticals, Wuhan Institute of Biological Products.
• Over half of the products are new molecular entities (NMEs)
• Pre-clinical and research phase companies offer huge opportunities for mergers, acquisitions and partnership options.
• Leading mechanism of action of most products include Interleukin 6 inhibitors
• 12 products present significant potential for development during 2020.

Scope of the Report

• 440 companies and products analyzed in the research
• Drug candidate, Vaccine candidate details including current status, companies involved, new molecular entity, phase, mechanism of action, recent developments, route of administration and other details analyzed for each candidate
• New molecular entities identified
• Clinical trials and related details provided for COVID-19 product candidates
• Recent COVID-19 pipeline developments in the industry are detailed

Companies included in the research

Phase 3-

AbCellera Biologics Inc , Ansun Biopharma Inc, AryoGen, AstraZeneca Plc, Bellerophon Therapeutics, Biocad, CytoDyn Inc, Eli Lilly and Company, FUJIFILM Toyama Chemical Co Ltd, Fulcrum Therapeutics, Gilead Sciences Inc, Insmed Inc, International Biotech Center Generium, Kowsar Biotechnology, Moderna Therapeutics Inc, Octapharma, OncoImmune Inc, Regeneron Pharmaceuticals Inc, Romark Laboratories LC, Serum Institute of India Ltd, Sinovac Biotech Ltd, Swedish Orphan Biovitrum AB, Vanda Pharmaceuticals Inc, Wuhan Institute of Biological Products Co Ltd, Abivax SA, Beijing Defengrei Biotechnology, Biohaven Pharmaceuticals Inc, BioNTech SE, Biophytis SA, Evelo Biosciences, FibroGen Inc, Immunic Inc, Inmunova SA, NeuroActiva Inc, Ono Pharmaceutical Co Ltd, PTC Therapeutics Inc, RedHill Biopharma Ltd, Swedish Orphan Biovitrum AB, Thirty respiratory Ltd

Phase 2-

4D Pharma PLC, AB Science, Acerta Pharma B.V., AI Therapeutics, Aldeyra Therapeutics Inc, Altum Pharmaceuticals Inc, Amarin Corp, Anhui Zhifei Longcom Biopharmaceutical, Apeiron Biologics GMBH, Applied Therapeutics Inc, Ascletis Pharma Inc, AstraZeneca Plc, Atea Pharmaceuticals Inc, aTyr Pharma Inc, Beech Tree Labs, BeiGene, BerGenBio SA, Blade Therapeutics Inc, Boehringer Ingelheim, Bristol-Myers Squibb Co, Bukwang Pharm Co Ltd, CalciMedica Inc, Can-Fite BioPharma Ltd, CinnaGen Co, Confluence Life Sciences Inc, Constant Therapeutics LLC, Eiger BioPharmaceuticals Inc, Eli Lilly and Company, Galecto Biotech, Genentech, GeneOne Life Science Inc, Globavir Biosciences Inc, Grifols SA, Heber Biotech SA, Heron Therapeutics Inc, Hope Biosciences LLC, Immune Therapeutics Inc, Inotrem SAA, Janssen Pharmaceuticals, Kancera AB, Karyopharm Therapeutics Inc, Kinevant Sciences Ltd, Laurent Pharmaceuticals Inc, Merck & Co, NeuroClear Technologies Inc, Novartis, Novartis AG, Novavax Inc, Pfizer Inc, PharmaMar SA, Pharming Group NV, PhaseBio Pharmaceuticals Inc, Pulmotect Inc, Reata Pharmaceuticals Inc, Relief Therapeutics Holdings AG, Renibus Therapeutics Inc, resTORbio Inc, Ridgeback Biotherapeutics LP, Roche AG, Rovi Corp, sanofi aventis, Sanotize Research and Development Corp, Synairgen Plc, Tianjin CanSino Biotechnology Inc, Tobira Therapeutics Inc, UCB Pharma, Vicore Pharma Holding AB , Viriom Inc, Vitaeris Inc, Xenothera, Zydus Cadila, Akari Therapeutics Plc, Arcturus Therapeutics Holdings Inc , Bharat Biotech International Ltd, Celularity Inc, Genexine Inc, I-MAB Biopharma Co Ltd, Immunitor Inc, Inovio Pharmaceuticals Inc, Janssen Pharmaceuticals, Janssen Vaccines and Prevention B.V, Kamada Ltd, Pacific Meinuoke Bio Pharmaceutical, Takara Bio Inc, Telios Pharmaceuticals Inc

Phase 1-

Ampio Pharmaceuticals Inc, argenx SE, AstraZeneca Plc, Atossa Therapeutics Inc, BioCryst Pharmaceuticals Inc, Brii Biosciences Ltd, Celltrion Inc, Clear Creek Bio, Clover Biopharmaceuticals Inc, Corvus Pharmaceuticals Inc, CureVac AG, Denali Therapeutics Inc, Dynavax Technologies Corp, Enlivex Therapeutics Ltd, ExeGi Pharma LLc, Fate Therapeutics Inc, Genexine Inc, Helperby Therapeutics Group Ltd , ImmuneMed Inc, Izana Bioscience, Medicago Inc, Palatin Technologies Inc, Pluristem Therapeutics Inc, ReiThera Srl, SAB Biotherapeutics Inc, Shanghai Junshi Bioscience Co Ltd, Sinocelltech Ltd, Themis Bioscience GmBH, Vaxine Pty Ltd, ychan Pte. Ltd.

IND/CTA Filed-

Agenus Inc, Algernon Pharmaceuticals Inc, Altimmune Inc, Better Life Pharmaceuticals Inc, Capricor Therapeutics, CytoAgents, Daewoong Pharmaceutical Co Ltd, Diffusion Pharmaceuticals Inc, Ensysce Biosciences Inc, GLW Pharma, ImmunityBio Inc, Kazia Therapeutics Ltd, Komipharm International Co Ltd, NovaLead Pharma Pvt Ltd, Novoteris LLC, Oncology Venture US, Organicell Regenerative Medicine Inc, Personalized Stem Cells Inc, Sun Pharmaceutical Industries Ltd, TC BioPharm Ltd, Union Therapeutics AS, VSY Biotechnology BV, Walvax Biotechnology Co Ltd

Preclinical-

60 Degrees Pharmaceuticals, 7 Hills Pharma LLC, AbbVie Inc, Abnova Corporation, Abound Bio, Acer Therapeutics Inc, Adagio Therapeutics, Adaptive Phage Therapeutics, AdaptVac, AIM ImmunoTech Inc, Akers Biosciences Inc, Aldeyra Therapeutics Inc, Anivive Lifesciences, Aptorum Group Limited, AriBio Co Ltd, Aridis Pharmaceuticals Inc, ARMS Pharmaceutical LLC, Array BioPharma Inc, AstraZeneca Plc, Atossa Therapeutics Inc, Berlin Cures Holding AG, Beyond Air Inc, BeyondSpring Inc, BioNet- Asia Co Ltd, BioNtech SE, Bio-Thera Solutions, BlueSky Immunotherapies, Bolder BioTechnology, Capricor Therapeutics Inc, CEL-SCI Corporation, Centivax, Chimeron Bio, ChromaDex, Cidara Therapeutics Inc, Cocrystal Pharma Inc, Codagenix Inc, COVAXX, COVID-19 Vaccine Corporation, Daiichi Sankyo Co Ltd, Delta 4, Dilafor AB, Dong Wha Pharmaceutical, Eagle Pharmaceuticals Inc, Elixirgen Therapeutics Inc, Emergent BioSolutions Inc, ENDECE LLC, Ennaid Therapeutics LLC, Entos Pharmaceuticals Inc, EpicentRx Inc, Epitopoietic Research Corporation, EpiVax Inc, eTheRNA Immunotherapies NV, EUCYT Laboratories LLC, Excision BioTherapeutics, ExeVir Bio, FibroGenesis LLC, FirstWave Bio, Flow Pharma Inc, GeneOne Life Science, GeoVax Labs, GigaGen Inc, Ginkgo Bioworks, Glycovax Pharma, GRDG Sciences, Grifols SA, HaloVax LLC, Heat Biologics Inc, HiFiBiO, Hoth Therapeutics, iBio Inc, IDBiologics Inc, IGY Life Sciences, Immodulon Therapeutics, IMV Inc, Inimmune, Innovation Pharmaceuticals Inc, INTELLiSTEM Technologies Inc, Isotechnika, Joseah Biopharma, Lineage Cell Therapeutics, LineaRx Inc, MedinCell S.A., Meissa Vaccines Inc, Memgen Corp, Merck & Co, Molecular Partners AG, Moleculin Biotech inc, Ology Bioservices Inc, Oncogenuity Inc, Oncology Venture, Oncolys BioPharma, Onconova Therapeutics, Oragenics Inc, OSE Immunotherapeutics, OyaGen Inc, PDS Biotechnology Corporation, PepTC Vaccines Limited, Precision NanoSystems Inc, Primmune Therapeutics Inc, Proteostasis Therapeutics Inc, Providence Therapeutics, Q BioMed Inc, Qualigen Therapeutics Inc, Radikal Therapeutics Inc, Rapa Therapeutics, Regeneron Pharmaceuticals Inc, Repurpose AI, Resverlogix Corp, RNAimmune Inc, Saiba AG, Sanofi pasteur, Sanofi SA, Secarna Pharmaceuticals GmbH&Co.KG, Selva Therapeutics, Senhwa Biosciences, Senzer Pharmaceuticals, Shanghai Junshi Biosciences Co Ltd, SK bioscience, Sorrento Therapeutics Inc, Spring Bank Pharmaceuticals Inc, Stabilitech Biopharma Ltd, Starpharma Holdings Ltd, Stemirna Therapeutics Co Ltd, Tonix Pharmaceuticals Holding Corp, UbiVac LLC, Vaxart Inc, Vaxil Bio Ltd, VBI Vaccines Inc, Verndari Inc, Vir Biotechnology Inc, Vivtex Corporation, Xiamen Innovax Biotech, YUMAB Gmbh, Zhittya Genesis Medicine, Zydus Cadila

Research-

48Hour Discovery Inc, A2A Pharmaceuticals Inc, Active Motif Inc, Adaptive Biotechnologies Inc, AdaptVac, Affinity Biosciences, AffyXell Therapeutics, AIkido Pharma Inc, Airway Therapeutics Inc, AJ Vaccines A/S, Akshaya Bio Inc, Aldevron, Aligos Therapeutics Inc, Alkido Pharma Inc, Amarillo Biosciences Inc, ANA Therapeutics, Anixa Biosciences Inc, Applied Biology Inc, Arbutus Biopharma Corp, Arrowhead Pharmaceuticals Inc, ARTES Biotechnology Gmbh, AstraZeneca Plc, Atreca Inc, AUM LifeTech Inc, Avacta Life Sciences Limited, Avalon GloboCare Corp, AvantGen Inc, Axon Neuroscience SE, Biocad, Biological E. Limited, Bioxytran Inc, Bold Therapeutics Inc, BriaCell Therapeutics Corp, CellPoint LLC, Chugai Pharmabody Research, Cobra Biologics Ltd, Codagenix Inc, Codiak BioSciences Inc, Cytovia Therapeutics Inc, Cyxone AB, Dyadic International Inc, Emergent BioSolutions Inc, Emergex vaccines Ltd, EpiVax Inc, Evotec Biologics, Exscientia Ltd, Generex Biotechnology Corp, Glycovax Pharma Inc, GT Biopharma, Hemogenyx Pharmaceuticals Plc, Hetero Labs Ltd, HiFiBiO Therapeutics, Hoth Therapeutics Inc, ImmuneCyte Inc, Immunomic Therapeutics Inc, ImmunoPrecise Antibodies Ltd, Imophoron Ltd, ImStem Biotechnology, Intravacc, Iontas Ltd, IVIEW Therapeutics Inc, Jiangsu Alphamab Biopharmaceuticals, kali-extracts Inc, Kleo Pharmaceuticals Inc, Ligandal Inc, Mabpharm Ltd, Manhattan BioSolutions LLC, Mateon Therapeutics Inc, Medivir AB, Memo Therapeutics AG, MigVax Ltd, Mymetics Corporation, NanoViricides Inc, Nascent Biotech Inc, Neovii Biotech, Neurimmune AG, Neutrolis Therapeutics, NuGenerex Immuno-Oncology Inc, OliX Pharmaceuticals Inc, OncoSec Medical Inc, Orgenesis Inc, OSIVAX, Panacea Biotec Ltd, PeptiDream Inc, Pfizer Inc, Phylex BioSciences Inc, Phytoption LLC, Pneumagen Ltd, Predictive Oncology, Prellis Biologics Inc, Prismic Pharmaceuticals, Qurient Co Ltd, Recce Pharmaceuticals, Regeneron Pharmaceuticals Inc, Replicate Bioscience, Sanofi Pasteur, Sarepta Therapeutics Inc, Scancell Holdings plc, Sirnaomics Inc, Sirona Biochem Corp, SmartPharm Therapeutics Inc, Soligenix Inc, SOM Biotech, Sosei Heptares, Sunshine Biopharma Inc, Synlogic Inc, Takeda, Takeda Pharmaceutical Company Ltd, Takis Biotech, Tetra Bio Pharma, Tevogen Bio, TFF pharmaceuticals Inc, Twist Bioscience Corp, Ufovax Inc, UMN Pharma Inc, United Biomedical Inc, Valneva SE, Valo Therapeutics Ltd, Vanda Pharmaceuticals Inc, Vaxil BioTherapeutics, Vir Biotechnology Inc, Viravaxx AG, Virna therapeutics, Vyripharm Biopharmaceuticals, WuXi Biologics Inc, Xbiotech, XORTX Therapeutics Inc

Contents

1 EXECUTIVE SUMMARY

1.1 Pipeline Snapshot- September 2020
1.2 Drug and Vaccine Pipeline Candidates by Phase
1.3 Drug and Vaccine Pipeline Candidates by New Molecular Entity (NME)
1.4 Drug and Vaccine Pipeline Candidates by Mechanism of Action

2 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE

2.1 AbCellera Biologics Inc COVID-19 Phase 3 Pipeline Analysis
  2.1.1 Current Status of the Pipeline Candidate
  2.1.2 Drug Overview
  2.1.3 Drug Mechanism of Action
  2.1.4 Route of Administration
  2.1.5 Companies involved in pipeline development
  2.1.6 New Molecular Entity status
  2.1.7 Clinical Trial Details
2.2 Ansun Biopharma Inc COVID-19 Phase 3 Pipeline Analysis
2.3 AryoGen COVID-19 Phase 3 Pipeline Analysis
2.4 AstraZeneca Plc COVID-19 Phase 3 Pipeline Analysis
2.5 Bellerophon Therapeutics COVID-19 Phase 3 Pipeline Analysis
2.6 Biocad COVID-19 Phase 3 Pipeline Analysis
2.7 CytoDyn Inc COVID-19 Phase 3 Pipeline Analysis
2.8 Eli Lilly and Company COVID-19 Phase 3 Pipeline Analysis
2.9 FUJIFILM Toyama Chemical Co Ltd COVID-19 Phase 3 Pipeline Analysis
2.10 Fulcrum Therapeutics COVID-19 Phase 3 Pipeline Analysis
2.11 Gilead Sciences Inc COVID-19 Phase 3 Pipeline Analysis
2.12 Insmed Inc COVID-19 Phase 3 Pipeline Analysis
2.13 International Biotech Center Generium COVID-19 Phase 3 Pipeline Analysis
2.14 Kowsar Biotechnology COVID-19 Phase 3 Pipeline Analysis
2.15 Moderna Therapeutics Inc COVID-19 Phase 3 Pipeline Analysis
2.16 Octapharma COVID-19 Phase 3 Pipeline Analysis
2.17 OncoImmune Inc COVID-19 Phase 3 Pipeline Analysis
2.18 Regeneron Pharmaceuticals Inc COVID-19 Phase 3 Pipeline Analysis
2.19 Romark Laboratories LC COVID-19 Phase 3 Pipeline Analysis
2.20 Serum Institute of India Ltd COVID-19 Phase 3 Pipeline Analysis
2.21 Sinovac Biotech Ltd COVID-19 Phase 3 Pipeline Analysis
2.22 Swedish Orphan Biovitrum AB COVID-19 Phase 3 Pipeline Analysis
2.23 Vanda Pharmaceuticals Inc COVID-19 Phase 3 Pipeline Analysis
2.24 Wuhan Institute of Biological Products Co Ltd COVID-19 Phase 3 Pipeline Analysis
2.25 Abivax SA COVID-19 Phase 3 Pipeline Analysis
2.26 Beijing Defengrei Biotechnology COVID-19 Phase 3 Pipeline Analysis
2.27 Biohaven Pharmaceuticals Inc COVID-19 Phase 3 Pipeline Analysis
2.28 BioNTech SE COVID-19 Phase 3 Pipeline Analysis
2.29 Biophytis SA COVID-19 Phase 3 Pipeline Analysis
2.30 Evelo Biosciences COVID-19 Phase 3 Pipeline Analysis
2.31 FibroGen Inc COVID-19 Phase 3 Pipeline Analysis
2.32 Immunic Inc COVID-19 Phase 3 Pipeline Analysis
2.33 Inmunova SA COVID-19 Phase 3 Pipeline Analysis
2.34 NeuroActiva Inc COVID-19 Phase 3 Pipeline Analysis
2.35 Ono Pharmaceutical Co Ltd COVID-19 Phase 3 Pipeline Analysis
2.36 PTC Therapeutics Inc COVID-19 Phase 3 Pipeline Analysis
2.37 RedHill Biopharma Ltd COVID-19 Phase 3 Pipeline Analysis
2.38 Swedish Orphan Biovitrum AB COVID-19 Phase 3 Pipeline Analysis
2.39 Thirty respiratory Ltd COVID-19 Phase 3 Pipeline Analysis

3 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE

3.1 4D Pharma PLC COVID-19 Phase 2 Pipeline Analysis
  3.1.1 Current Status of the Pipeline Candidate
  3.1.2 Drug Overview
  3.1.3 Drug Mechanism of Action
  3.1.4 Route of Administration
  3.1.5 Companies involved in pipeline development
  3.1.6 New Molecular Entity status
  3.1.7 Clinical Trial Details
3.2 4D Pharma PLC COVID-19 Phase 2 Pipeline Analysis
3.3 AB Science COVID-19 Phase 2 Pipeline Analysis
3.4 Acerta Pharma B.V. COVID-19 Phase 2 Pipeline Analysis
3.5 AI Therapeutics COVID-19 Phase 2 Pipeline Analysis
3.6 Aldeyra Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.7 Altum Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.8 Amarin Corp COVID-19 Phase 2 Pipeline Analysis
3.9 Anhui Zhifei Longcom Biopharmaceutical COVID-19 Phase 2 Pipeline Analysis
3.10 Apeiron Biologics GMBH COVID-19 Phase 2 Pipeline Analysis
3.11 Applied Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.12 Ascletis Pharma Inc COVID-19 Phase 2 Pipeline Analysis
3.13 AstraZeneca Plc COVID-19 Phase 2 Pipeline Analysis
3.14 Atea Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.15 aTyr Pharma Inc COVID-19 Phase 2 Pipeline Analysis
3.16 Beech Tree Labs COVID-19 Phase 2 Pipeline Analysis
3.17 BeiGene COVID-19 Phase 2 Pipeline Analysis
3.18 BerGenBio SA COVID-19 Phase 2 Pipeline Analysis
3.19 Blade Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.20 Boehringer Ingelheim COVID-19 Phase 2 Pipeline Analysis
3.21 Bristol-Myers Squibb Co COVID-19 Phase 2 Pipeline Analysis
3.22 Bukwang Pharm Co Ltd COVID-19 Phase 2 Pipeline Analysis
3.23 CalciMedica Inc COVID-19 Phase 2 Pipeline Analysis
3.24 Can-Fite BioPharma Ltd COVID-19 Phase 2 Pipeline Analysis
3.25 CinnaGen Co COVID-19 Phase 2 Pipeline Analysis
3.26 Confluence Life Sciences Inc COVID-19 Phase 2 Pipeline Analysis
3.27 Constant Therapeutics LLC COVID-19 Phase 2 Pipeline Analysis
3.28 Eiger BioPharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.29 Eli Lilly and Company COVID-19 Phase 2 Pipeline Analysis
3.30 Galecto Biotech COVID-19 Phase 2 Pipeline Analysis
3.31 Genentech COVID-19 Phase 2 Pipeline Analysis
3.32 GeneOne Life Science Inc COVID-19 Phase 2 Pipeline Analysis
3.33 Globavir Biosciences Inc COVID-19 Phase 2 Pipeline Analysis
3.34 Grifols SA COVID-19 Phase 2 Pipeline Analysis
3.35 Heber Biotech SA COVID-19 Phase 2 Pipeline Analysis
3.36 Heron Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.37 Hope Biosciences LLC COVID-19 Phase 2 Pipeline Analysis
3.38 Immune Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.39 Inotrem SAA COVID-19 Phase 2 Pipeline Analysis
3.40 Janssen Pharmaceuticals COVID-19 Phase 2 Pipeline Analysis
3.41 Kancera AB COVID-19 Phase 2 Pipeline Analysis
3.42 Karyopharm Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.43 Kinevant Sciences Ltd COVID-19 Phase 2 Pipeline Analysis
3.44 Laurent Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.45 Merck & Co COVID-19 Phase 2 Pipeline Analysis
3.46 NeuroClear Technologies Inc COVID-19 Phase 2 Pipeline Analysis
3.47 Novartis COVID-19 Phase 2 Pipeline Analysis
3.48 Novartis AG COVID-19 Phase 2 Pipeline Analysis
3.49 Novavax Inc COVID-19 Phase 2 Pipeline Analysis
3.50 Pfizer Inc COVID-19 Phase 2 Pipeline Analysis
3.51 PharmaMar SA COVID-19 Phase 2 Pipeline Analysis
3.52 Pharming Group NV COVID-19 Phase 2 Pipeline Analysis
3.53 PhaseBio Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.54 Pulmotect Inc COVID-19 Phase 2 Pipeline Analysis
3.55 Reata Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.56 Relief Therapeutics Holdings AG COVID-19 Phase 2 Pipeline Analysis
3.57 Renibus Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.58 resTORbio Inc COVID-19 Phase 2 Pipeline Analysis
3.59 Ridgeback Biotherapeutics LP COVID-19 Phase 2 Pipeline Analysis
3.60 Roche AG COVID-19 Phase 2 Pipeline Analysis
3.61 Rovi Corp COVID-19 Phase 2 Pipeline Analysis
3.62 sanofi aventis COVID-19 Phase 2 Pipeline Analysis
3.63 Sanotize Research and Development Corp COVID-19 Phase 2 Pipeline Analysis
3.64 Synairgen Plc COVID-19 Phase 2 Pipeline Analysis
3.65 Tianjin CanSino Biotechnology Inc COVID-19 Phase 2 Pipeline Analysis
3.66 Tobira Therapeutics Inc COVID-19 Phase 2 Pipeline Analysis
3.67 UCB Pharma COVID-19 Phase 2 Pipeline Analysis
3.68 Vicore Pharma Holding AB COVID-19 Phase 2 Pipeline Analysis
3.69 Viriom Inc COVID-19 Phase 2 Pipeline Analysis
3.70 Vitaeris Inc COVID-19 Phase 2 Pipeline Analysis
3.71 Xenothera COVID-19 Phase 2 Pipeline Analysis
3.72 Zydus Cadila COVID-19 Phase 2 Pipeline Analysis
3.73 Akari Therapeutics Plc COVID-19 Phase 2 Pipeline Analysis
3.74 Arcturus Therapeutics Holdings Inc COVID-19 Phase 2 Pipeline Analysis
3.75 Bharat Biotech International Ltd COVID-19 Phase 2 Pipeline Analysis
3.76 Celularity Inc COVID-19 Phase 2 Pipeline Analysis
3.77 Genexine Inc COVID-19 Phase 2 Pipeline Analysis
3.78 I-MAB Biopharma Co Ltd COVID-19 Phase 2 Pipeline Analysis
3.79 Immunitor Inc COVID-19 Phase 2 Pipeline Analysis
3.80 Inovio Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis
3.81 Janssen Pharmaceuticals COVID-19 Phase 2 Pipeline Analysis
3.82 Janssen Vaccines and Prevention B.V COVID-19 Phase 2 Pipeline Analysis
3.83 Kamada Ltd COVID-19 Phase 2 Pipeline Analysis
3.84 Pacific Meinuoke Bio Pharmaceutical COVID-19 Phase 2 Pipeline Analysis
3.85 Takara Bio Inc COVID-19 Phase 2 Pipeline Analysis
3.86 Telios Pharmaceuticals Inc COVID-19 Phase 2 Pipeline Analysis

4 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE

4.1 Ampio Pharmaceuticals Inc COVID-19 Phase 1 Pipeline Analysis
  4.1.1 Current Status of the Pipeline Candidate
  4.1.2 Drug Overview
  4.1.3 Drug Mechanism of Action
  4.1.4 Route of Administration
  4.1.5 Companies involved in pipeline development
  4.1.6 New Molecular Entity status
  4.1.7 Clinical Trial Details
4.2 Ampio Pharmaceuticals Inc COVID-19 Phase 1 Pipeline Analysis
4.3 argenx SE COVID-19 Phase 1 Pipeline Analysis
4.4 AstraZeneca Plc COVID-19 Phase 1 Pipeline Analysis
4.5 Atossa Therapeutics Inc COVID-19 Phase 1 Pipeline Analysis
4.6 BioCryst Pharmaceuticals Inc COVID-19 Phase 1 Pipeline Analysis
4.7 Brii Biosciences Ltd COVID-19 Phase 1 Pipeline Analysis
4.8 Celltrion Inc COVID-19 Phase 1 Pipeline Analysis
4.9 Clear Creek Bio COVID-19 Phase 1 Pipeline Analysis
4.10 Clover Biopharmaceuticals Inc COVID-19 Phase 1 Pipeline Analysis
4.11 Corvus Pharmaceuticals Inc COVID-19 Phase 1 Pipeline Analysis
4.12 CureVac AG COVID-19 Phase 1 Pipeline Analysis
4.13 Denali Therapeutics Inc COVID-19 Phase 1 Pipeline Analysis
4.14 Dynavax Technologies Corp COVID-19 Phase 1 Pipeline Analysis
4.15 Enlivex Therapeutics Ltd COVID-19 Phase 1 Pipeline Analysis
4.16 ExeGi Pharma LLc COVID-19 Phase 1 Pipeline Analysis
4.17 Fate Therapeutics Inc COVID-19 Phase 1 Pipeline Analysis
4.18 Genexine Inc COVID-19 Phase 1 Pipeline Analysis
4.19 Helperby Therapeutics Group Ltd COVID-19 Phase 1 Pipeline Analysis
4.20 ImmuneMed Inc COVID-19 Phase 1 Pipeline Analysis
4.21 Izana Bioscience COVID-19 Phase 1 Pipeline Analysis
4.22 Medicago Inc COVID-19 Phase 1 Pipeline Analysis
4.23 Palatin Technologies Inc COVID-19 Phase 1 Pipeline Analysis
4.24 Pluristem Therapeutics Inc COVID-19 Phase 1 Pipeline Analysis
4.25 ReiThera Srl COVID-19 Phase 1 Pipeline Analysis
4.26 SAB Biotherapeutics Inc COVID-19 Phase 1 Pipeline Analysis
4.27 Shanghai Junshi Bioscience Co Ltd COVID-19 Phase 1 Pipeline Analysis
4.28 Sinocelltech Ltd COVID-19 Phase 1 Pipeline Analysis
4.29 Themis Bioscience GmBH COVID-19 Phase 1 Pipeline Analysis
4.30 Vaxine Pty Ltd COVID-19 Phase 1 Pipeline Analysis
4.31 ychan Pte. Ltd. COVID-19 Phase 1 Pipeline Analysis

5 COVID-19 COMPANIES AND DRUG CANDIDATES IN IND/CTA FILED PHASE

5.1 Agenus Inc COVID-19 IND/CTA Phase Pipeline Analysis
  5.1.1 Current Status of the Pipeline Candidate
  5.1.2 Drug Overview
  5.1.3 Drug Mechanism of Action
  5.1.4 Route of Administration
  5.1.5 Companies involved in pipeline development
  5.1.6 New Molecular Entity status
  5.1.7 Clinical Trial Details
5.2 Algernon Pharmaceuticals Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.3 Altimmune Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.4 Better Life Pharmaceuticals Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.5 Capricor Therapeutics COVID-19 IND/CTA Phase Pipeline Analysis
5.6 CytoAgents COVID-19 IND/CTA Phase Pipeline Analysis
5.7 Daewoong Pharmaceutical Co Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.8 Diffusion Pharmaceuticals Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.9 Ensysce Biosciences Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.10 GLW Pharma COVID-19 IND/CTA Phase Pipeline Analysis
5.11 ImmunityBio Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.12 Kazia Therapeutics Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.13 Komipharm International Co Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.14 NovaLead Pharma Pvt Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.15 Novoteris LLC COVID-19 IND/CTA Phase Pipeline Analysis
5.16 Oncology Venture US COVID-19 IND/CTA Phase Pipeline Analysis
5.17 Organicell Regenerative Medicine Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.18 Personalized Stem Cells Inc COVID-19 IND/CTA Phase Pipeline Analysis
5.19 Sun Pharmaceutical Industries Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.20 TC BioPharm Ltd COVID-19 IND/CTA Phase Pipeline Analysis
5.21 Union Therapeutics AS COVID-19 IND/CTA Phase Pipeline Analysis
5.22 VSY Biotechnology BV COVID-19 IND/CTA Phase Pipeline Analysis
5.23 Walvax Biotechnology Co Ltd COVID-19 IND/CTA Phase Pipeline Analysis

6 COVID-19 COMPANIES AND DRUG CANDIDATES IN PRECLINICAL PHASE

6.1 60 Degrees Pharmaceuticals COVID-19 Preclinical Phase Pipeline Analysis
  6.1.1 Current Status of the Pipeline Candidate
  6.1.2 Drug Overview
  6.1.3 Drug Mechanism of Action
  6.1.5 Companies involved in pipeline development
  6.1.6 New Molecular Entity status
6.2- 7 Hills Pharma LLC COVID-19 Preclinical Phase Pipeline Analysis
6.3 AbbVie Inc COVID-19 Preclinical Phase Pipeline Analysis
6.4 Abnova Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.5 Abound Bio COVID-19 Preclinical Phase Pipeline Analysis
6.6 Acer Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.7 Adagio Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.8 Adaptive Phage Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.9 AdaptVac COVID-19 Preclinical Phase Pipeline Analysis
6.10 AIM ImmunoTech Inc COVID-19 Preclinical Phase Pipeline Analysis
6.11 Akers Biosciences Inc COVID-19 Preclinical Phase Pipeline Analysis
6.12 Aldeyra Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.13 Anivive Lifesciences COVID-19 Preclinical Phase Pipeline Analysis
6.14 Aptorum Group Limited COVID-19 Preclinical Phase Pipeline Analysis
6.15 AriBio Co Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.16 Aridis Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.17 ARMS Pharmaceutical LLC COVID-19 Preclinical Phase Pipeline Analysis
6.18 Array BioPharma Inc COVID-19 Preclinical Phase Pipeline Analysis
6.19 AstraZeneca Plc COVID-19 Preclinical Phase Pipeline Analysis
6.20 Atossa Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.21 Berlin Cures Holding AG COVID-19 Preclinical Phase Pipeline Analysis
6.22 Beyond Air Inc COVID-19 Preclinical Phase Pipeline Analysis
6.23 BeyondSpring Inc COVID-19 Preclinical Phase Pipeline Analysis
6.24 BioNet- Asia Co Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.25 BioNtech SE COVID-19 Preclinical Phase Pipeline Analysis
6.26 Bio-Thera Solutions COVID-19 Preclinical Phase Pipeline Analysis
6.27 BlueSky Immunotherapies COVID-19 Preclinical Phase Pipeline Analysis
6.28 Bolder BioTechnology COVID-19 Preclinical Phase Pipeline Analysis
6.29 Capricor Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.30 CEL-SCI Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.31 Centivax COVID-19 Preclinical Phase Pipeline Analysis
6.32 Chimeron Bio COVID-19 Preclinical Phase Pipeline Analysis
6.33 ChromaDex COVID-19 Preclinical Phase Pipeline Analysis
6.34 Cidara Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.35 Cocrystal Pharma Inc COVID-19 Preclinical Phase Pipeline Analysis
6.36 Codagenix Inc COVID-19 Preclinical Phase Pipeline Analysis
6.37 COVAXX COVID-19 Preclinical Phase Pipeline Analysis
6.38 COVID-19 Vaccine Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.39 Daiichi Sankyo Co Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.40 Delta 4 COVID-19 Preclinical Phase Pipeline Analysis
6.41 Dilafor AB COVID-19 Preclinical Phase Pipeline Analysis
6.42 Dong Wha Pharmaceutical COVID-19 Preclinical Phase Pipeline Analysis
6.43 Eagle Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.44 Elixirgen Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.45 Emergent BioSolutions Inc COVID-19 Preclinical Phase Pipeline Analysis
6.46 ENDECE LLC COVID-19 Preclinical Phase Pipeline Analysis
6.47 Ennaid Therapeutics LLC COVID-19 Preclinical Phase Pipeline Analysis
6.48 Entos Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.49 EpicentRx Inc COVID-19 Preclinical Phase Pipeline Analysis
6.50 Epitopoietic Research Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.51 EpiVax Inc COVID-19 Preclinical Phase Pipeline Analysis
6.52 eTheRNA Immunotherapies NV COVID-19 Preclinical Phase Pipeline Analysis
6.53 EUCYT Laboratories LLC COVID-19 Preclinical Phase Pipeline Analysis
6.54 Excision BioTherapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.55 ExeVir Bio COVID-19 Preclinical Phase Pipeline Analysis
6.56 FibroGenesis LLC COVID-19 Preclinical Phase Pipeline Analysis
6.57 FirstWave Bio COVID-19 Preclinical Phase Pipeline Analysis
6.58 Flow Pharma Inc COVID-19 Preclinical Phase Pipeline Analysis
6.59 GeneOne Life Science COVID-19 Preclinical Phase Pipeline Analysis
6.60 GeoVax Labs COVID-19 Preclinical Phase Pipeline Analysis
6.61 GigaGen Inc COVID-19 Preclinical Phase Pipeline Analysis
6.62 Ginkgo Bioworks COVID-19 Preclinical Phase Pipeline Analysis
6.63 Glycovax Pharma COVID-19 Preclinical Phase Pipeline Analysis
6.64 GRDG Sciences COVID-19 Preclinical Phase Pipeline Analysis
6.65 Grifols SA COVID-19 Preclinical Phase Pipeline Analysis
6.66 HaloVax LLC COVID-19 Preclinical Phase Pipeline Analysis
6.67 Heat Biologics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.68 HiFiBiO COVID-19 Preclinical Phase Pipeline Analysis
6.69 Hoth Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.70 iBio Inc COVID-19 Preclinical Phase Pipeline Analysis
6.71 IDBiologics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.72 IGY Life Sciences COVID-19 Preclinical Phase Pipeline Analysis
6.73 Immodulon Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.74 IMV Inc COVID-19 Preclinical Phase Pipeline Analysis
6.75 Inimmune COVID-19 Preclinical Phase Pipeline Analysis
6.76 Innovation Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.77 INTELLiSTEM Technologies Inc COVID-19 Preclinical Phase Pipeline Analysis
6.78 Isotechnika COVID-19 Preclinical Phase Pipeline Analysis
6.79 Joseah Biopharma COVID-19 Preclinical Phase Pipeline Analysis
6.80 Lineage Cell Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.81 LineaRx Inc COVID-19 Preclinical Phase Pipeline Analysis
6.82 MedinCell S.A. COVID-19 Preclinical Phase Pipeline Analysis
6.83 Meissa Vaccines Inc COVID-19 Preclinical Phase Pipeline Analysis
6.84 Memgen Corp COVID-19 Preclinical Phase Pipeline Analysis
6.85 Merck & Co COVID-19 Preclinical Phase Pipeline Analysis
6.86 Molecular Partners AG COVID-19 Preclinical Phase Pipeline Analysis
6.87 Moleculin Biotech inc COVID-19 Preclinical Phase Pipeline Analysis
6.88 Ology Bioservices Inc COVID-19 Preclinical Phase Pipeline Analysis
6.89 Oncogenuity Inc COVID-19 Preclinical Phase Pipeline Analysis
6.90 Oncology Venture COVID-19 Preclinical Phase Pipeline Analysis
6.91 Oncolys BioPharma COVID-19 Preclinical Phase Pipeline Analysis
6.92 Onconova Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.93 Oragenics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.94 OSE Immunotherapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.95 OyaGen Inc COVID-19 Preclinical Phase Pipeline Analysis
6.96 PDS Biotechnology Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.97 PepTC Vaccines Limited COVID-19 Preclinical Phase Pipeline Analysis
6.98 Precision NanoSystems Inc COVID-19 Preclinical Phase Pipeline Analysis
6.99 Primmune Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.100 Proteostasis Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.101 Providence Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.102 Q BioMed Inc COVID-19 Preclinical Phase Pipeline Analysis
6.103 Qualigen Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.104 Radikal Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.105 Rapa Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.106 Regeneron Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.107 Repurpose AI COVID-19 Preclinical Phase Pipeline Analysis
6.108 Resverlogix Corp COVID-19 Preclinical Phase Pipeline Analysis
6.109 RNAimmune Inc COVID-19 Preclinical Phase Pipeline Analysis
6.110 Saiba AG COVID-19 Preclinical Phase Pipeline Analysis
6.111 Sanofi pasteur COVID-19 Preclinical Phase Pipeline Analysis
6.112 Sanofi SA COVID-19 Preclinical Phase Pipeline Analysis
6.113 Secarna Pharmaceuticals GmbH&Co.KG COVID-19 Preclinical Phase Pipeline Analysis
6.114 Selva Therapeutics COVID-19 Preclinical Phase Pipeline Analysis
6.115 Senhwa Biosciences COVID-19 Preclinical Phase Pipeline Analysis
6.116 Senzer Pharmaceuticals COVID-19 Preclinical Phase Pipeline Analysis
6.117 Shanghai Junshi Biosciences Co Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.118 SK bioscience COVID-19 Preclinical Phase Pipeline Analysis
6.119 Sorrento Therapeutics Inc COVID-19 Preclinical Phase Pipeline Analysis
6.120 Spring Bank Pharmaceuticals Inc COVID-19 Preclinical Phase Pipeline Analysis
6.121 Stabilitech Biopharma Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.122 Starpharma Holdings Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.123 Stemirna Therapeutics Co Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.124 Tonix Pharmaceuticals Holding Corp COVID-19 Preclinical Phase Pipeline Analysis
6.125 UbiVac LLC COVID-19 Preclinical Phase Pipeline Analysis
6.126 Vaxart Inc COVID-19 Preclinical Phase Pipeline Analysis
6.127 Vaxil Bio Ltd COVID-19 Preclinical Phase Pipeline Analysis
6.128 VBI Vaccines Inc COVID-19 Preclinical Phase Pipeline Analysis
6.129 Verndari Inc COVID-19 Preclinical Phase Pipeline Analysis
6.130 Vir Biotechnology Inc COVID-19 Preclinical Phase Pipeline Analysis
6.131 Vivtex Corporation COVID-19 Preclinical Phase Pipeline Analysis
6.132 Xiamen Innovax Biotech COVID-19 Preclinical Phase Pipeline Analysis
6.133 YUMAB Gmbh COVID-19 Preclinical Phase Pipeline Analysis
6.134 Zhittya Genesis Medicine COVID-19 Preclinical Phase Pipeline Analysis
6.135 Zydus Cadila COVID-19 Preclinical Phase Pipeline Analysis

7 COVID-19 COMPANIES AND DRUG CANDIDATES IN RESEARCH PHASE

7.1 48Hour Discovery Inc Research Phase Pipeline Analysis
  7.1.1 Current Status of the Pipeline Candidate
  7.1.2 Drug Overview
  7.1.3 Drug Mechanism of Action
  7.1.4 Route of Administration
  7.1.5 Companies involved in pipeline development
7.2 7.2 48Hour Discovery Inc COVID-19 Research Phase Pipeline Analysis
7.3 A2A Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.4 Active Motif Inc COVID-19 Research Phase Pipeline Analysis
7.5 Adaptive Biotechnologies Inc COVID-19 Research Phase Pipeline Analysis
7.6 AdaptVac COVID-19 Research Phase Pipeline Analysis
7.7 Affinity Biosciences COVID-19 Research Phase Pipeline Analysis
7.8 AffyXell Therapeutics COVID-19 Research Phase Pipeline Analysis
7.9 AIkido Pharma Inc COVID-19 Research Phase Pipeline Analysis
7.10 Airway Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.11 AJ Vaccines A/S COVID-19 Research Phase Pipeline Analysis
7.12 Akshaya Bio Inc COVID-19 Research Phase Pipeline Analysis
7.13 Aldevron COVID-19 Research Phase Pipeline Analysis
7.14 Aligos Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.15 Alkido Pharma Inc COVID-19 Research Phase Pipeline Analysis
7.16 Amarillo Biosciences Inc COVID-19 Research Phase Pipeline Analysis
7.17 ANA Therapeutics COVID-19 Research Phase Pipeline Analysis
7.18 Anixa Biosciences Inc COVID-19 Research Phase Pipeline Analysis
7.19 Applied Biology Inc COVID-19 Research Phase Pipeline Analysis
7.20 Arbutus Biopharma Corp COVID-19 Research Phase Pipeline Analysis
7.21 Arrowhead Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.22 ARTES Biotechnology Gmbh COVID-19 Research Phase Pipeline Analysis
7.23 AstraZeneca Plc COVID-19 Research Phase Pipeline Analysis
7.24 Atreca Inc COVID-19 Research Phase Pipeline Analysis
7.25 AUM LifeTech Inc COVID-19 Research Phase Pipeline Analysis
7.26 Avacta Life Sciences Limited COVID-19 Research Phase Pipeline Analysis
7.27 Avalon GloboCare Corp COVID-19 Research Phase Pipeline Analysis
7.28 AvantGen Inc COVID-19 Research Phase Pipeline Analysis
7.29 Axon Neuroscience SE COVID-19 Research Phase Pipeline Analysis
7.30 Biocad COVID-19 Research Phase Pipeline Analysis
7.31 Biological E. Limited COVID-19 Research Phase Pipeline Analysis
7.32 Bioxytran Inc COVID-19 Research Phase Pipeline Analysis
7.33 Bold Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.34 BriaCell Therapeutics Corp COVID-19 Research Phase Pipeline Analysis
7.35 CellPoint LLC COVID-19 Research Phase Pipeline Analysis
7.36 Chugai Pharmabody Research COVID-19 Research Phase Pipeline Analysis
7.37 Cobra Biologics Ltd COVID-19 Research Phase Pipeline Analysis
7.38 Codagenix Inc COVID-19 Research Phase Pipeline Analysis
7.39 Codiak BioSciences Inc COVID-19 Research Phase Pipeline Analysis
7.40 Cytovia Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.41 Cyxone AB COVID-19 Research Phase Pipeline Analysis
7.42 Dyadic International Inc COVID-19 Research Phase Pipeline Analysis
7.43 Emergent BioSolutions Inc COVID-19 Research Phase Pipeline Analysis
7.44 Emergex vaccines Ltd COVID-19 Research Phase Pipeline Analysis
7.45 EpiVax Inc COVID-19 Research Phase Pipeline Analysis
7.46 Evotec Biologics COVID-19 Research Phase Pipeline Analysis
7.47 Exscientia Ltd COVID-19 Research Phase Pipeline Analysis
7.48 Generex Biotechnology Corp COVID-19 Research Phase Pipeline Analysis
7.49 Glycovax Pharma Inc COVID-19 Research Phase Pipeline Analysis
7.50 GT Biopharma COVID-19 Research Phase Pipeline Analysis
7.51 Hemogenyx Pharmaceuticals Plc COVID-19 Research Phase Pipeline Analysis
7.52 Hetero Labs Ltd COVID-19 Research Phase Pipeline Analysis
7.53 HiFiBiO Therapeutics COVID-19 Research Phase Pipeline Analysis
7.54 Hoth Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.55 ImmuneCyte Inc COVID-19 Research Phase Pipeline Analysis
7.56 Immunomic Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.57 ImmunoPrecise Antibodies Ltd COVID-19 Research Phase Pipeline Analysis
7.58 Imophoron Ltd COVID-19 Research Phase Pipeline Analysis
7.59 ImStem Biotechnology COVID-19 Research Phase Pipeline Analysis
7.60 Intravacc COVID-19 Research Phase Pipeline Analysis
7.61 Iontas Ltd COVID-19 Research Phase Pipeline Analysis
7.62 IVIEW Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.63 Jiangsu Alphamab Biopharmaceuticals COVID-19 Research Phase Pipeline Analysis
7.64 kali-extracts Inc COVID-19 Research Phase Pipeline Analysis
7.65 Kleo Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.66 Ligandal Inc COVID-19 Research Phase Pipeline Analysis
7.67 Mabpharm Ltd COVID-19 Research Phase Pipeline Analysis
7.68 Manhattan BioSolutions LLC COVID-19 Research Phase Pipeline Analysis
7.69 Mateon Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.70 Medivir AB COVID-19 Research Phase Pipeline Analysis
7.71 Memo Therapeutics AG COVID-19 Research Phase Pipeline Analysis
7.72 MigVax Ltd COVID-19 Research Phase Pipeline Analysis
7.73 Mymetics Corporation COVID-19 Research Phase Pipeline Analysis
7.74 NanoViricides Inc COVID-19 Research Phase Pipeline Analysis
7.75 Nascent Biotech Inc COVID-19 Research Phase Pipeline Analysis
7.76 Neovii Biotech COVID-19 Research Phase Pipeline Analysis
7.77 Neurimmune AG COVID-19 Research Phase Pipeline Analysis
7.78 Neutrolis Therapeutics COVID-19 Research Phase Pipeline Analysis
7.79 NuGenerex Immuno-Oncology Inc COVID-19 Research Phase Pipeline Analysis
7.80 OliX Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.81 OncoSec Medical Inc COVID-19 Research Phase Pipeline Analysis
7.82 Orgenesis Inc COVID-19 Research Phase Pipeline Analysis
7.83 OSIVAX COVID-19 Research Phase Pipeline Analysis
7.84 Panacea Biotec Ltd COVID-19 Research Phase Pipeline Analysis
7.85 PeptiDream Inc COVID-19 Research Phase Pipeline Analysis
7.86 Pfizer Inc COVID-19 Research Phase Pipeline Analysis
7.87 Phylex BioSciences Inc COVID-19 Research Phase Pipeline Analysis
7.88 Phytoption LLC COVID-19 Research Phase Pipeline Analysis
7.89 Pneumagen Ltd COVID-19 Research Phase Pipeline Analysis
7.90 Predictive Oncology COVID-19 Research Phase Pipeline Analysis
7.91 Prellis Biologics Inc COVID-19 Research Phase Pipeline Analysis
7.92 Prismic Pharmaceuticals COVID-19 Research Phase Pipeline Analysis
7.93 Qurient Co Ltd COVID-19 Research Phase Pipeline Analysis
7.94 Recce Pharmaceuticals COVID-19 Research Phase Pipeline Analysis
7.95 Regeneron Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.96 Replicate Bioscience COVID-19 Research Phase Pipeline Analysis
7.97 Sanofi Pasteur COVID-19 Research Phase Pipeline Analysis
7.98 Sarepta Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.99 Scancell Holdings plc COVID-19 Research Phase Pipeline Analysis
7.100 Sirnaomics Inc COVID-19 Research Phase Pipeline Analysis
7.101 Sirona Biochem Corp COVID-19 Research Phase Pipeline Analysis
7.102 SmartPharm Therapeutics Inc COVID-19 Research Phase Pipeline Analysis
7.103 Soligenix Inc COVID-19 Research Phase Pipeline Analysis
7.104 SOM Biotech COVID-19 Research Phase Pipeline Analysis
7.105 Sosei Heptares COVID-19 Research Phase Pipeline Analysis
7.106 Sunshine Biopharma Inc COVID-19 Research Phase Pipeline Analysis
7.107 Synlogic Inc COVID-19 Research Phase Pipeline Analysis
7.108 Takeda COVID-19 Research Phase Pipeline Analysis
7.109 Takeda Pharmaceutical Company Ltd COVID-19 Research Phase Pipeline Analysis
7.110 Takis Biotech COVID-19 Research Phase Pipeline Analysis
7.111 Tetra Bio Pharma COVID-19 Research Phase Pipeline Analysis
7.112 Tevogen Bio COVID-19 Research Phase Pipeline Analysis
7.113 TFF pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.114 Twist Bioscience Corp COVID-19 Research Phase Pipeline Analysis
7.115 Ufovax Inc COVID-19 Research Phase Pipeline Analysis
7.116 UMN Pharma Inc COVID-19 Research Phase Pipeline Analysis
7.117 United Biomedical Inc COVID-19 Research Phase Pipeline Analysis
7.118 Valneva SE COVID-19 Research Phase Pipeline Analysis
7.119 Valo Therapeutics Ltd COVID-19 Research Phase Pipeline Analysis
7.120 Vanda Pharmaceuticals Inc COVID-19 Research Phase Pipeline Analysis
7.121 Vaxil BioTherapeutics COVID-19 Research Phase Pipeline Analysis
7.122 Vir Biotechnology Inc COVID-19 Research Phase Pipeline Analysis
7.123 Viravaxx AG COVID-19 Research Phase Pipeline Analysis
7.124 Virna therapeutics COVID-19 Research Phase Pipeline Analysis
7.125 Vyripharm Biopharmaceuticals COVID-19 Research Phase Pipeline Analysis
7.126 WuXi Biologics Inc COVID-19 Research Phase Pipeline Analysis
7.127 Xbiotech COVID-19 Research Phase Pipeline Analysis
7.128 XORTX Therapeutics Inc COVID-19 Research Phase Pipeline Analysis

8 LATEST COVID-19 MARKET DEVELOPMENTS

9. APPENDIX

9.1 Sources and Methodology
9.2 About the Publisher